HCM
ABVX

Harvey Capital Management’s Abivax ABVX Stock Holding History

Harvey Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$479K Buy
4,300
+1,000
+30% +$118K 0.11% 62
2025
Q4 		$445K Buy
+3,300
New +$360K 0.09% 63

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Harvey Capital Management's ABVX Position: Q1 2026 in Review

Harvey Capital Management increased its Abivax (ABVX) stake by 30% in Q1 2026, buying an estimated $118K and bringing the position to 4,300 shares worth $479K. The position accounts for 0.11% of the portfolio, ranked #62.

Harvey Capital Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Harvey Capital Management held 4,300 shares of Abivax worth $479K as of Q1 2026.
  • Harvey Capital Management bought 1,000 Abivax shares in Q1 2026, an estimated $118K.
  • Abivax made up 0.11% of Harvey Capital Management's portfolio in Q1 2026, its #62 holding.
  • Harvey Capital Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Harvey Capital Management's 13F filing for Q1 2026, filed 11 May 2026.